A Ament
Overview
Explore the profile of A Ament including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gordeev V, Maksymowych W, Evers S, Ament A, Schachna L, Boonen A
Ann Rheum Dis
. 2009 Mar;
69(1):108-12.
PMID: 19282311
Background: In the bio-psycho-social model of health, the role of contextual factors, either environmental or personal, is recognised. Objective: To assess the impact of a number of contextual factors on...
2.
Nulens E, Broex E, Ament A, Deurenberg R, Smeets E, Scheres J, et al.
J Hosp Infect
. 2008 Mar;
68(4):301-7.
PMID: 18353496
Costs related to a search and destroy policy and treatment for Staphylococcus aureus bacteraemia in the University Hospital Maastricht were calculated for the period 2000 and 2004. The financial cost-benefit...
3.
Dolders M, Nijkamp M, Nuijts R, van den Borne B, Hendrikse F, Ament A, et al.
Br J Ophthalmol
. 2004 Aug;
88(9):1163-8.
PMID: 15317709
Aim: To analyse the cost effectiveness of foldable monofocal intraocular lenses (IOLs) compared to foldable multifocal IOLs in cataract surgery alongside a prospective, multicentre randomised clinical trial (RCT). Methods: Patients...
4.
Ament A, Fedson D, Christie P
Clin Infect Dis
. 2001 Nov;
33(12):2078-9.
PMID: 11700581
Most studies of the cost-effectiveness of pneumococcal vaccination show very favorable cost-effectiveness ratios for preventing pneumococcal pneumonia, but they make the controversial assumption that vaccination is equally effective in preventing...
5.
Ament A
Int J Technol Assess Health Care
. 2001 Aug;
17(3):451-4.
PMID: 11495388
No abstract available.
6.
Ortqvist A, Jonsson B, Baltussen R, Ament A
Lakartidningen
. 2000 Dec;
97(45):5120-5.
PMID: 11116891
The pneumococcal vaccine has been shown to be about 70 percent efficacious in preventing invasive pneumococcal disease in elderly persons. In a European multicenter study, pneumococcal vaccination was moderately cost-effective...
7.
De Graeve D, Verhaegen J, Ament A, Baltussen R
Acta Clin Belg
. 2000 Dec;
55(5):257-65.
PMID: 11109640
Background: Several studies have shown that pneumococcal vaccination of older persons would be cost-effective in preventing pneumococcal pneumonia, but evidence of clinical protection for this condition is uncertain. Given much...
8.
Ament A, Baltussen R, Duru G, De Graeve D, Ortqvist A, Jonsson B, et al.
Clin Infect Dis
. 2000 Sep;
31(2):444-50.
PMID: 10987703
Pneumococcal vaccination of older persons is thought to be cost-effective in preventing pneumococcal pneumonia, but evidence of clinical protection is uncertain. Because there is better evidence of vaccination effectiveness against...
9.
Ament A, Evers S, Baltussen R
Cerebrovasc Dis
. 2000 Jul;
10(4):283-8.
PMID: 10878433
Economic evaluation is becoming increasingly important in the field of stroke as well. The results of economic evaluation can be expressed in cost per quality-adjusted life years (QALY) gained, which...
10.
Baltussen R, Leidl R, Ament A
Pharmacoeconomics
. 2000 Feb;
16(5 Pt 1):449-58.
PMID: 10662392
This paper identifies the information that economic evaluation should provide to adequately inform policy-makers. First, policy-makers need cost-effectiveness information that is both internally and externally valid. The latter aspect is...